Phibro Animal Health (PAHC) Raw Materials (2013 - 2026)

Phibro Animal Health has reported Raw Materials for 14 years, with the latest figure at $195.0 million in Q2 2026.

• On a quarterly basis, Raw Materials rose 19.89% year-over-year to $195.0 million in Q2 2026; TTM through Jun 2026 was $195.0 million, a 19.89% increase from a year earlier, with the FY2026 full-year figure at $195.0 million, up 19.89% from the prior year.
• Raw Materials was $195.0 million for Q2 2026 at Phibro Animal Health, up from $191.7 million in the prior quarter.
• The five-year high for Raw Materials was $195.0 million in Q2 2026, with the low at $72.8 million in Q2 2024.
• Average Raw Materials over 5 years is $117.3 million, with a median of $91.0 million recorded in 2022.
• The sharpest annual moves came in 2023 and 2025: Raw Materials retreated 20.21% in 2023, then surged 123.39% in 2025.
• Over 5 years, Raw Materials stood at $96.6 million in 2022, then retreated by 20.21% to $77.0 million in 2023, then soared by 89.35% to $145.9 million in 2024, then grew by 22.34% to $178.5 million in 2025, then grew by 9.25% to $195.0 million in 2026.
• The last three Raw Materials figures came in at $195.0 million (Q2 2026), $191.7 million (Q1 2026), and $178.5 million (Q4 2025), per Business Quant data.